Enterobacteriaceae that are resistant to carbapenem antimicrobials through the production of carbapenemase are known as carbapenamase-producing Enterobacteriaceae (CPE). Because CPE are resistant to many antibiotics that are considered the last line of defense, treatment of infections with CPE is difficult.
Public Health Ontario (PHO) in collaboration with the Ministry of Health and Long‐Term Care (MOHLTC) initiated a voluntary surveillance program to assess the epidemiology of CPE in Ontario. In 2011, the Chief Medical Officer of Health emphasized the importance of surveillance to understand the burden and transmission of this antibiotic resistant organism in a letter to the hospitals and Local Health Integration Networks:
Epidemiological data is critical for informing infection prevention and control policies and procedures that will help prevent the likelihood of CPE becoming endemic in Ontario. For questions and comments related to CPE surveillance contact us at email@example.com.